Literature DB >> 21656321

Anesthetic considerations in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome: a case series.

Carmelina Gurrieri1, Jonathon E Kivela, Katarina Bojanić, Ralitza H Gavrilova, Randall P Flick, Juraj Sprung, Toby N Weingarten.   

Abstract

PURPOSE: Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome (MELAS) is a rare inherited mitochondrial disorder associated with severe multiorgan pathology and stress-induced episodes of metabolic decompensation and lactic acidosis. The purpose of this case series is to review the medical records of patients with MELAS who underwent anesthetic care at the Mayo Clinic to observe their perioperative responses to anesthesia and to assess outcomes. PRINCIPAL
FINDINGS: From September 1997 to October 2010, nine patients with MELAS were identified who underwent 20 general anesthetics, 12 prior to MELAS diagnosis. Debilitating neurologic symptoms involved eight patients, and three patients had substantial cardiac comorbidities. The patients tolerated commonly used anesthetics and muscle relaxants, including succinylcholine. Lactated Ringer's solution was used frequently. One patient was noted to have elevated postoperative serum lactate, but his serum lactate was chronically elevated. Metabolic acidosis was not observed in any patient. Hyponatremia and hyperkalemia, sometimes profound, were observed in seven patients, but these abnormalities also occurred at times remote from surgery. Two patients developed renal dysfunction following cardiac surgery and abdominal surgery for severe sepsis.
CONCLUSION: The MELAS patients developed episodes of hyponatremia and hyperkalemia of variable severity unrelated to the timing of surgery, suggesting these patients are prone to major electrolyte disturbances. Given the propensity to develop acid-base disturbances and lactacidemia, it is prudent to review and normalize electrolyte abnormalities and to adjust the anesthetic plan accordingly. Fortunately, the limited data suggest that patients with MELAS tolerate commonly used anesthetic drugs well.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21656321     DOI: 10.1007/s12630-011-9528-0

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  11 in total

1.  Potentially diagnostic electron paramagnetic resonance spectra elucidate the underlying mechanism of mitochondrial dysfunction in the deoxyguanosine kinase deficient rat model of a genetic mitochondrial DNA depletion syndrome.

Authors:  Brian Bennett; Daniel Helbling; Hui Meng; Jason Jarzembowski; Aron M Geurts; Marisa W Friederich; Johan L K Van Hove; Michael W Lawlor; David P Dimmock
Journal:  Free Radic Biol Med       Date:  2016-01-08       Impact factor: 7.376

2.  [Characteristics of anesthesia in patients with MELAS syndrome: Case report of anesthesia in video-assisted thoracoscopy].

Authors:  A Haas; F Wappler
Journal:  Anaesthesist       Date:  2015-08-28       Impact factor: 1.041

3.  Anesthetic Management in Mitochondrial Encephalomyopathy: A Case Report.

Authors:  Toru Yamamoto; Noriko Miyazawa; Shinichi Yamamoto; Hiroshi Kawahara
Journal:  Anesth Prog       Date:  2017

Review 4.  Anesthesia for children with mitochondrial disorders: a national survey and review.

Authors:  Muhammad B Rafique; Staci D Cameron; Qaiser Khan; Suur Biliciler; Salman Zubair
Journal:  J Anesth       Date:  2012-09-25       Impact factor: 2.078

5.  Treatment of mitochondrial disorders.

Authors:  Sreenivas Avula; Sumit Parikh; Scott Demarest; Jonathan Kurz; Andrea Gropman
Journal:  Curr Treat Options Neurol       Date:  2014-06       Impact factor: 3.598

6.  Case report: perioperative management of caesarean section for a parturient with mitochondrial myopathy.

Authors:  Qiang Zheng; Penghui Wei; Jinfeng Zhou; Haipeng Zhou; Fucheng Ji; Wenxi Tang; Jianjun Li
Journal:  BMC Anesthesiol       Date:  2017-07-12       Impact factor: 2.217

Review 7.  Anaesthesia and neuromuscular disorders: what a neurologist needs to know.

Authors:  Heinz Jungbluth; Nicol C Voermans; Luuk R van den Bersselaar; Marc M J Snoeck; Madelief Gubbels; Sheila Riazi; Erik-Jan Kamsteeg
Journal:  Pract Neurol       Date:  2020-10-27

8.  Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neuropsychiatr Dis Treat       Date:  2017-10-06       Impact factor: 2.570

Review 9.  Mapping the current evidence on the anesthetic management of adult patients with neuromuscular disorders-a scoping review.

Authors:  Luuk R van den Bersselaar; Madelief Gubbels; Sheila Riazi; Luc Heytens; Heinz Jungbluth; Nicol C Voermans; Marc M J Snoeck
Journal:  Can J Anaesth       Date:  2022-03-23       Impact factor: 6.713

Review 10.  Endocrine disorders in mitochondrial disease.

Authors:  Andrew M Schaefer; Mark Walker; Douglass M Turnbull; Robert W Taylor
Journal:  Mol Cell Endocrinol       Date:  2013-06-13       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.